Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 4 6Phase 2 3Phase 1 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Leiomyoma 1Dupuytren Contracture 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Microbial Collagenase × Clear all
NCT02889848 2019-07-10

Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)

Advance Biofactures Corporation

Phase 1 Completed
15 enrolled

Leiomyoma

NCT00528931 2017-10-05

A Pharmacokinetic Study of AA4500 (XIAFLEXâ„¢, Proposed Name) in Subjects With Dupuytren's Contracture

Endo Pharmaceuticals

Phase 1 Completed
16 enrolled 11 charts

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon âš¡